Saturday June 29

tentative program

Saturday morning sessions 08:00 – 12:00 hours

Factor  VIII and IX, part I (Elicium 2)

08:00
Education Session:  Session Chairpersons
Steven Pipe (USA) / Danijela Mikovic (Serbia) / Peter Collins (UK)

09:00
Report on SSC-FVIII&FIX activity 2012 – 2013

09:20
Clinical outcome evaluation – methods:Session Chairpersons
Elisa Mancuso (Italy) or Alberto Tosetto (Italy)

10:20
Inhibitor development – methods and results
Koen Mertens (The Netherlands) / Gary Gilbert (USA) / Pier Mannuccio Mannucci (Italy) / Marijke van den Berg (The Netherlands) / Alfonso Iorio (Canada)

Animal Models (Elicium 1)

08:00
Educational Session: Humanized Animal Models – their role in drug discovery/validation
Nigel Key (USA) / Thomas Diacovo (USA) / Henri Spronk (The Netherlands)

09:15
Subcommittee Session
David Motto (USA) / Fumiaki Banno (Japan) / Hitomi Yamamoto (Japan) / Tom Knudsen (Denmark) / Timothy Nichols (USA)

Lupus Anticoagulant/Phospholipid-Dependent Antibodies (Forum)

08:00
Education Session
Katrien Devreese (Belgium) / Hilde Kelchtermans (The Netherlands) / Keith McCrae (USA)

09:10
Subcommittee Session
Denis Wahl (France) / Elaine Gray (UK) / Rolf Urbanus (The Netherlands) / Thomas L. Ortel (USA) / Katrien Devreese (Belgium) / Silvia Pierangeli (USA) / Denis Wahl (France) / Thomas L. Ortel (USA)

Platelet Immunology (Mondriaan II)

08:00
Welcome
Yves Gruel (France)

08:05
Education Session
Andreas Greinacher (Germany) / Adam Cuker (USA)

09:05
Autoimmune and drug-induced thrombocytopenia
Donald Arnold (Canada) / Volker Kiefel (Germany) / Yoshiaki Tomiyam (Japan) / Martine Jandrot-Perrus (France)

09:45
Alloimmune thrombocytopenia: Basic Research
Jallu V (France)

09:55
Alloimmune thrombocytopenia: Diagnosis
Sentot Santoso and Tamam Bakchoul (Germany) / J T. Peterson (USA) Allen DL, UK – ISBT / Gian P. Visentin (USA)

10:30
Treatment
Bjorn Skogen (Norway) / Tamam Bakchoul and Sentot Santoso (Germany)

10:55
Heparin-induced thrombocytopenia
Steven McKenzie (USA) / Adam Cuker (USA) / Gian P. Visentin (USA) Christopher Ward (Australia) / Theodore Warkentin (Canada) Yves Gruel (France)

Fibrinolysis (Mondriaan III)

08:00
Education session: Unexpected/unconventional factors that partake inupregulation of fibrinolysis
Krasimir Kolev (Hungary) / Ed Pryzdial (Canada)/ Eduardo Angles-Cano (France)

09:00
Subcommittee Session
Laurent Plawinski and Eduardo Angles-Cano (France) / Aleksandra Antovic (Sweden), Danijela Mikovic, Fariborz Mobarrez, M. Zabczyk, Shu He, Ivo Elezovic, K. Hutenby, Barry Woodhams, Jovan Antovic / Nicola Mutch (UK) / Colin Longstaff (UK) / Craig Thelwell (UK) / Tine Wyseure, Ann Gils and Paul Declerck (Belgium) / Dorien Leenaerts and Dirk Hendriks (Belgium) / Michael Boffa (Canada) / Jonathan Foley (Canada) / Waander Van Heerde (The Netherlands) / Karel Moons (The Netherlands) / Shannon Bates (Canada) / Ann Gils (Belgium)

Predictive Variables in Cardiovascular Disease (Mondriaan IV)

08:00
New Approaches to Predict Thrombosis Risk + Update of SSC Research
Jim Douketis (Canada)

08:05
Educational Session: CHADS2, CHA2DS2VASc and New Approaches to Predicting Thrombosis Risk
Michiel Coppens (The Netherlands) / Marc C. Samama (France)

09:20
Update of SSC Research and Related Activities
John Eikelboom (Canada) / Robert Campbell Tait (UK) / AlexSpyropoulos (USA) / Paolo Prandoni (Italy) / Marc Rodger (Cananda) and Gregoire Le Gal (France) / Gordon Lowe (UK) / Karel Moons and Geert-Jan Geersing (The Netherlands) / James Douketis (Canada)

Vascular Biology (08:00 – 11:50)

08:00
Education Session
Florence Toti-Orfanoudakis (France) / Michael G. Tomlinson (UK) / Anna M. Randi (UK)

09:00
Subcommittee Session : Shedded protein and receptors
Robert Andrews (Australia) / Giovanni Davi (Italy) / Lawrence F. Brass  (USA)

10:15
Subcommittee Session: Circulating endothelial cells and progenitors
David Smadja (France) / Michael Hristov (DE) / Edwin van der Pol (The Netherlands) / Chris Gardiner (UK) / Samir El Andaloussi (UK) / Esther Nolte-’t Hoen (NL)

11:30
Subcommittee Session: Standardization
Rienk Nieuwland (The Netherlands) / Romaric Lacroix (France) / Françoise Dignat-George (France)

Educational sessions (12:00 – 14:00 hours) Forum Room

12:00
Welcoming lunch* for all recipients of Reach-the-World and Young Investigators Awards
*lunch by invitation only

13:00
“The do’s and don’ts of attending a conference”
Prof. dr Frits R. Rosendaal
Professor of Clinical Epidemiology, Departments of Clinical Epidemiology and Thrombosis and Haemostasis
Leiden University Medical Center, the Netherlands

13:10
“Cited and be damned: the view of a science impact scientist”
Prof. dr Ton van Raan
Professor of Quantitative Studies of Science
Centre for Science and Technology Studies (CWTS) at Leiden University, The Netherlands.

13:35
“From silliness to fraud: the view of a science journalist”
Hans van Maanen, MSc
Science journalist for Dutch journals and author of several books. Visiting lecturer Science Journalism at Rotterdam University.

Working Group on Genomics in Hemostasis (E104-107)

12:00
First Session
Graham Kiddle (UK) / Kathleen Freson (Belgium)

13:00
Second Session
Augusto Rendon (UK) / Mingdong Huang (USA) – TBC / Bruno Villoutreix (France) – TBC / Willem H Ouwehand (UK)

Saturday afternoon sessions 14:00 – 18:00 hours

Factor VIII and IX, part II (Elicium 2)

14:00
New hemostatic drugs: classification, dose stardadisation and monitoring
Donna Di Michele (USA) / Sebastein Lacroix-Desmasez (France) / Brian O’Mahony(Ireland) / Guy Young (USA) / Andrew Lawrie (UK)

15:30
Assays standardization
Steve Kitchen (UK) / Vince Jenkins (Ireland)

16:25
Orphan drugs in Rare Bleeding Disorders (RBDs)
Danijela Mikovic (Serbia) / Amy Simon (USA) / Claudia Nardini (Kedrion, Italy)

17:15
OPEN SESSION ON NEW PROPOSALS
Alok Srivastava (India) / Anneliese Hilger (EMEA) / Nisha Jain (FDA)

17:39
New SSC Projects
Elena Santagostino (Italy) / Carmen Escuriola (Germany) / Victor Blanchette (Canada)

Fibrinogen and Factor XIII (Elicium I)

14:00
Education Session
Helen Philippou (UK) / John Weisel (USA)

15:00
Subcommittee Session
Verena Schroeder and Hans Kohler (Switzerland) / Sanj Raut (UK) / Robert Ariens (UK) / Helena Handrková, Verena Schroeder and Hans P Kohler (Switzerland) / Marguerite Neerman-Arbez (Switzerland) / Catherine J Rea and Benny Sorenson (UK) / Rustem Litvinov (USA) /Éva Katona and László Muszbek (Hungary) / Aki Ichinose (Japan) / Vytautas Ivaskevicius (Germany)

Women’s Health in Thrombosis & Hemostasis (Mondriaan II)

14:00
Educational session
Claire McLintock (New Zealand) / Astrid van Hylckama Vlieg (The Netherlands) / Sabine Eichinger (Austria) / Benjamin Brenner (Israel)

15:15
Thrombosis Issues
Melanie Tan and  Menno Huisman(The Netherlands) / Lisbeth Eischer (Austria)

16:10
Thrombophilia and Pregnancy
Maria T. DeSancho (USA) / Elvira Grandone (Italy) / Reiko Neki (Japan) /Claire McLintock (New Zealand) / Saskia Middeldorp (The Netherlands)

17:25
Haemostasis Issues (chair: Rezan Kadir, UK)
Claire McLintock (New Zealand) / Rochelle Winikoff (Canada) / Sabine Eichinger (Austria)

Plasma Coagulation Inhibitors (Mondriaan III)

14:00
Education Session
Peter Cooper (UK) / Laurent Burnier (Switzerland) / Piet Meijer (The Netherlands) / Richard Marlar (USA) / Ingrid Hrachovinova (Czech republic)

16:10
Molecular genetics
Elisabetta Castoldi (The Netherlands) / Hiroko Tsuda ( Japan) / Anna Pavlova ( Germany)

16:55
Standardisation of Protein S activity assays
Steve Kitchen  (UK)

Hemostasis and Malignancy (Mondriaan IV)

14:00
Education Session
Agnes Y. Lee (Canada) / Chris Holmes (USA) / Thomas Ortel (USA)

15:00
Session One: Clinical Guidance
Marc Carrier (Canada) / Jeffrey Zwicker (USA) / Alok Khorana (USA) / Agnes Y. Lee (Canada)

16:30
Session Two: Clinical and Translational Updates
Joseph Palumbo (USA) / Ingrid Pabinger and Cihan Ay (Austria) / Marc Carrier (Canada) / Henri H. Versteeg (The Netherlands) / (CATCH- Lee, PHACS-Khorana, SOME-Carrier, PERIOP-Carrier, LONGHEVA-Kamphuisen, TILT-Meyer, Incidental VTE treatment –DiNisio, CAT IQ – Zwicker)

Biorheology (E102)

14:00
Educational Session: Flow-based assays of thrombosis and hemostasis
Keith Neeves (USA) / Johan Heemskerk (The Netherlands) / Lawrence Brass (USA)

15:00
Session 2: Mechanical degradation of VWF in medical devices
Vincent Turitto (USA) and Zoe Demou / Sriram Neelamegham (USA) / X. Long Zheng (USA) / David Ku (USA) / Rong He (USA)

17:10
Session 3: Emerging Topics in Biorheology
Owen McCarty (USA) / Michael King (USA)